Nathan Connell/LinkedIn
Sep 29, 2025, 04:51
Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Vasculearn Network shared on LinkedIn:
”A major step forward for people living with hemophilia, and our very own Nathan Connell, MD, MPH, FACP, VLN Chair of Clinician Education, was one of the lead physicians behind this groundbreaking research.
A new gene therapy could reduce — or even eliminate — the need for regular infusions, giving patients more freedom in their daily lives.
This new approach delivers a functional gene to the liver, helping patients produce clotting factor IX—a protein that plays a critical role in the clotting process.
Watch the full CBS News segment here.”
Stay updated with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?